Technology | Quality Assurance (QA) | April 27, 2018

Sun Nuclear Launches SunCheck 2.0

Complete platform enables integrated, independent quality assurance in radiation

Designed to support a broad range of planning and delivery technologies, SunCheck 2.0 streamlines and standardizes workflows, allowing greater overall focus on patient safety.

April 27, 2018 — Sun Nuclear Corp. released significant new functionality for its SunCheck Platform for patient and machine quality assurance (QA) in radiation therapy. Designed to support a broad range of planning and delivery technologies, SunCheck 2.0 streamlines and standardizes workflows, allowing greater overall focus on patient safety.  

With SunCheck, hospitals and cancer centers gain:

  • One solution for radiation therapy QA. Managing all patient and machine QA in a consistent way helps reduce the likelihood of errors going undetected;
  • Speed and efficiency through automation. Less time spent on manual tasks means more bandwidth for data analysis, clinical decisions and continuous improvement; and
  • Access from anywhere. SunCHECK is browser-based and accessible to staff through a secure network. From dashboard reviews to deep data analysis, a single database drives the entire process.

Within the SunCheck Platform, SunCheck Patient integrates all phases of patient QA into a seamless workflow, including secondary checks, phantomless pre-treatment QA and in-vivo monitoring.

Key new functionality includes:

  • EPID-based Transit Dosimetry, compliant with 2013/59/EURATOM, Article 83;
  • Pre-set, yet customizable, dose tolerances per phase, with Universal Metrics; and
  • Expanded 3-D secondary dose and MU calculation support, including for TomoTherapy (Monte Carlo-based), high dose rate (HDR) brachytherapy and stereotactic cone systems.

SunCheck Machine helps to improve standardization and ease compliance reporting for daily, monthly and annual QA across locations, machines and staff.

Key new functionality includes:

  • Standard and complete TG-142 templates;
  • User-friendly editing or creation of customized QA templates and tasks;
  • Direct device connectivity to Sun Nuclear’s Daily QA 3 and IC Profiler solutions; and
  • Centralized data storage and flexible reporting for accreditation and compliance.

SunCheck 2.0 featured in the Sun Nuclear booth at the 2018 European Society for Radiotherapy and Oncology Congress (ESTRO 37), April 20-24 in Barcelona, Spain.

For more information: www.sunnuclear.com

 

Related Content

Breast cancer patients whose disease has spread to their brains fare better if their metastases are picked up before they begin to cause symptoms, according to a study presented at the 12th European Breast Cancer Conference.

Getty Images

News | September 21, 2020
September 21, 2020 — Breast cancer patients whose disease has spread to their brains fare better if their metastases
Data from latest research presented at the ESMO Virtual Congress 2020 suggests COVID-19 pandemic halts cancer care and damages oncologists' wellbeing

Getty Images

News | Coronavirus (COVID-19) | September 17, 2020
September 17, 2020 — Delays and cancellation of cancer treatments and other safety measures undertaken to minimize th
the Contrast Media Injectors Market is estimated to be USD 1.3 billion in 2020 and  projected to reach $1.9B by 2025, at a CAGR of 7.4% between 2020 and 2025

Getty Images

News | Contrast Media Injectors | September 02, 2020
September 2, 2020 — According to the new market research report "...
Single-dose radiotherapy replaces need for extra hospital visits, with benefits for patient safety and well-being

Getty Images

News | Women's Health | August 20, 2020
August 20, 2020— For most women with early breast cancer
A special issue of the Journal of Medical Imaging and Radiation Sciences features stories about the interpersonal skills beyond the technical aspects to care for and guide patients through medical imaging and radiation therapy procedures

Image courtesy of Canon

News | Patient Engagement | August 11, 2020
August 11, 2020 — "I went into the MRI
Global radiotherapy market revenue is set to expand from $7,222.4 million in 2019 to $17,194.4 million by 2030, at an 8.4% CAGR between 2020 and 2030, the key factor driving the market growth is the increasing number of cancer cases, according to the report published by P&S Intelligence.

Image courtesy of Elekta

News | Radiation Therapy | August 06, 2020
August 6, 2020 — Global ...
Siemens AG is continuing to rigorously execute its Vision 2020+ strategy and therefore expressly welcomes Siemens Healthineers AG’s acquisition of a 100 percent stake in Varian Medical Systems, Inc., a U.S. company active in the area of cancer research and therapy.

Getty Images

News | Radiology Business | August 03, 2020
August 3, 2020 — Siemens AG is continuing to rigorously execute its Vision 2020+ strategy and therefore expressly wel
JAMA Oncol. Published online  July 30, 2020. doi:10.1001/jamaoncol.2020.2783

Table 1. JAMA Oncol. Published online  July 30, 2020. doi:10.1001/jamaoncol.2020.2783

News | Coronavirus (COVID-19) | July 31, 2020
July 31, 2020 — An article published in JAMA...